Order Article Reprints

Trapp EK, Fasching PA, Fehm T, Schneeweiss A, Mueller V, Harbeck N, Lorenz R, Schumacher C, Heinrich G, Schochter F, et al. Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial. Cancers. 2022; 14(16):3949. https://doi.org/10.3390/cancers14163949

Trapp, Elisabeth K., Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Volkmar Mueller, Nadia Harbeck, Ralf Lorenz, Claudia Schumacher, Georg Heinrich, Fabienne Schochter, and et al. 2022. "Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial" Cancers 14, no. 16: 3949. https://doi.org/10.3390/cancers14163949

Trapp, E. K., Fasching, P. A., Fehm, T., Schneeweiss, A., Mueller, V., Harbeck, N., Lorenz, R., Schumacher, C., Heinrich, G., Schochter, F., de Gregorio, A., Tzschaschel, M., Rack, B., Janni, W., & Friedl, T. W. P. (2022). Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial. Cancers, 14(16), 3949. https://doi.org/10.3390/cancers14163949